Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. j. med. biol. res ; 30(11): 1333-6, Nov. 1997. graf
Article Dans Anglais | LILACS | ID: lil-201679

Résumé

We determined the effect of the antioxidants superoxide dismutase, desferrioxamine and allopurinol on the survival of male CBA mice infected intranasally with 2-5 LD50 lung influenza virus A/Aichi/2/68. Survival for at least 20 days was observed for 45 percent of the mice that received 1000 U/day superoxide dismutase prepared from red blood cells on days 5,6,7 and 8 after infection, and 75 percent survival was observed for mice that received the same dose on days 4,5,6,7 and 8. Desferrioxamine, 25 mg/kg per day and 100 mg/kg per day injected subcutaneously, resulted in survival rates of 5 and 0 percent, respectively, compared to 10 percent survival observed for saline-injected controls. Allopurinol at doses of 5 to 50 mg/kg per day had no effect on mouse survival. These data demonstrate the efficacy of superoxide dismutase for the protection of mice against hemorrhagic lung edema. The ineffectiveness of allopurinol suggest that the xanthine oxidase system does not play a major role in hemorrhage or lung edema and that caution is necessary when desferrioxamine is administered during an acute inflammatory process accompanied by erythrocyte lysis.


Sujets)
Animaux , Mâle , Souris , Allopurinol/usage thérapeutique , Antioxydants/usage thérapeutique , Déferoxamine/usage thérapeutique , Virus de la grippe A/effets des médicaments et des substances chimiques , Grippe humaine/traitement médicamenteux , Superoxide dismutase/usage thérapeutique , Modèles animaux de maladie humaine , Dose létale 50 , Souris de lignée CBA
SÉLECTION CITATIONS
Détails de la recherche